Milanese M, Di Marco F, Corsico A G, Rolla G, Sposato B, Chieco-Bianchi F, Costantino M T, Crivellaro M A, Guarnieri G, Scichilone N
Struttura Complessa di Pneumologia, Azienda Sanitaria Locale 2 Savonese, Pietra Ligure, Italy.
Struttura Complessa di Pneumologia Ospedale S. Paolo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Italy.
Respir Med. 2014 Aug;108(8):1091-9. doi: 10.1016/j.rmed.2014.05.016. Epub 2014 Jun 9.
The exponential increase of individuals aged >64 yrs is expected to impact the burden of asthma. We aimed to explore the level of asthma control in elderly subjects, and factors influencing it.
A multicenter observational study was performed on consecutive patients >64 years old with a documented physician-diagnosis of asthma. Sixteen Italian centers were involved in this 6-month project.
A total of 350 patients were enrolled in the study. More than one-third of elderly asthmatic patients, despite receiving GINA step 3-4 antiasthmatic therapy, had an Asthma Control Test score ≤19, with a quarter experiencing at least one severe asthma exacerbation in the previous year. Twenty-nine percent of patients (n = 101) were classified as having Asthma-COPD Overlap Syndrome (ACOS) due to the presence of chronic bronchitis and/or CO lung diffusion impairment. This subgroup of patients had lower mean Asthma Control Test scores and more exacerbations compared to the asthmatic patients (18 ± 4 compared to 20 ± 4, p < 0.01, and 43% compared to 18%, p < 0.01, respectively). Modified Medical Research Council dyspnea mMRC scores and airway obstruction, assessed on the basis of a FEV(1)/FVC ratio below the lower limit of normal, were more severe in ACOS than in asthma, without any difference in responses to salbutamol. In a multivariate analysis, the mMRC dyspnea score, FEV(1)% of predicted and the coexistence of COPD were the only variables to enter the model.
Our results highlight the need to specifically evaluate the coexistence of features of COPD in elderly asthmatics, a factor that worsens asthma control.
预计64岁以上人群数量的指数增长将影响哮喘负担。我们旨在探讨老年受试者的哮喘控制水平及其影响因素。
对连续入选的64岁以上有医生确诊哮喘记录的患者进行多中心观察性研究。16个意大利中心参与了这个为期6个月的项目。
共有350例患者纳入研究。超过三分之一的老年哮喘患者尽管接受了全球哮喘防治创议(GINA)3 - 4级抗哮喘治疗,但哮喘控制测试(ACT)评分≤19,四分之一的患者在前一年至少经历过一次严重哮喘发作。29%的患者(n = 101)因存在慢性支气管炎和/或一氧化碳肺弥散功能障碍而被归类为患有哮喘 - 慢性阻塞性肺疾病重叠综合征(ACOS)。与哮喘患者相比,该亚组患者的平均ACT评分更低,发作更频繁(分别为18±4与20±4,p < 0. .01;43%与18%,p < 0.01)。基于低于正常下限的第一秒用力呼气容积(FEV₁)/用力肺活量(FVC)比值评估的改良医学研究委员会呼吸困难量表(mMRC)评分和气道阻塞在ACOS患者中比哮喘患者更严重,而对沙丁胺醇的反应无差异。在多变量分析中,mMRC呼吸困难评分、预测的FEV₁%以及COPD的共存是进入模型的唯一变量。
我们的结果强调了需要特别评估老年哮喘患者中COPD特征的共存情况,这是一个会使哮喘控制恶化的因素。